SHERRIA NORWOOD: Open Payments
NPI 1649844978 · COLQUITT, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$328 in 17 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $607 · 2025 $328
Food & beverage: $328
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 3 | $49 |
| Eisai Inc. | 2 | $45 |
| GlaxoSmithKline, LLC. | 2 | $38 |
| E.R. Squibb & Sons, L.L.C. | 2 | $33 |
| Astellas Pharma US Inc | 1 | $25 |
| TAIHO ONCOLOGY, INC. | 1 | $24 |
| Regeneron Healthcare Solutions, Inc. | 1 | $24 |
| Janssen Biotech, Inc. | 1 | $20 |
| BeOne Medicines USA, Inc. | 1 | $20 |
| Gilead Sciences, Inc. | 1 | $18 |
Products named: Lenvima, SCEMBLIX, OPDIVO, Vyloy, LONSURF, LIBTAYO, OJJAARA, BRUKINSA.
Industry payments across GA — which companies pay providers there.
